Céline Gélinas, Ph.D.

Céline Gélinas, Ph.D.

Senior Associate Dean for Research
Professor and Chair of Biochemistry and Molecular Biology
Rutgers, Robert Wood Johnson Medical School
Resident Member, Center for Advanced Biotechnology and Medicine

(848) 445-9802



Dr. Gélinas serves as Senior Associate Dean for Research at the Robert Wood Johnson Medical School (RWJMS) within the Rutgers Biomedical and Health Sciences (RBHS) network of Rutgers University. She previously served as Associate Dean for Research and institutional official from 2008-13, overseeing research administration and compliance for RWJMS. In her current role, Dr. Gélinas is responsible for all research programs at RWJMS. In this role, she brought the adult and the pediatric Clinical Research Centers in New Brunswick under common leadership, to provide state-of-the-art support for innovative clinical and translational research at RWJMS and with our partners across NJ ACTS, and to offer access for children and adults to clinical trials involving the newest treatments. Under her leadership, the CRC was designated as a Cystic Fibrosis Therapeutics Development Center.

Since she joined Rutgers, following post-doctoral training with Nobel Laureate Dr. Howard M. Temin at the McArdle Laboratory for Cancer Research at the University of Wisconsin, Dr. Gélinas’ basic and translational research has focused on the NF-kappa B signaling pathway that regulates gene expression and plays fundamental roles in cancer development and progression, and in the cellular response to viruses and other pathogens. Her work has provided important insights into mechanisms of disease ranging from viral infection to cancer, metastasis and chemoresistance, and has identified several potential therapeutic targets. She is also collaborating on translational studies aimed at eliminating the latent arm of HIV-1 infection to help in the development of new therapies to allow for total clearance. She is PI on an NIH R33 grant and was the PI on NIH R01 grants for over 22 years. She has served on several NIH study sections and has published over 60 peer-reviewed articles, book chapters and invited reviews.